Status | Study |
Completed |
Study Name: Biomarkers for Oral Cancer Condition: Lichen Planus Oral Leukoplakia Date: 2006-06-19 |
Completed |
Study Name: Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia Condition: Lip and Oral Cavity Cancer Oral Leukoplakia Date: 2006-05-25 Interventions: Drug: Bowman-Birk inhibitor concentrate |
Active, not recruiting |
Study Name: A Randomized Study of Sulindac in Oral Premalignant Lesions Condition: Leukoplakia, Oral Benign Neoplasms Date: 2006-03-02 Interventions: Drug: sulindac Sulindac 150 mg |
Terminated |
Study Name: A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia Condition: Oral Leukoplakia Date: 2005-09-12 Interventions: Drug: Lozenge Intake of green tea lozenges weighing 6 grams each, containing 0.45 grams of green tea sol |
Completed |
Study Name: Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia Condition: Oral Leukoplakia Date: 2005-09-08 Interventions: Procedure: photodynamic therapy |
Completed |
Study Name: Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia Condition: Head and Neck Cancer Precancerous Condition Date: 2005-01-07 Interventions: Drug: celecoxib |
Completed |
Study Name: Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia Condition: Head and Neck Cancer Oral Leukoplakia Date: 2004-12-08 Interventions: Drug: pioglitazone hydrochloride Given PO Other Name |
Completed |
Study Name: Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia Condition: Head and Neck Cancer Date: 2003-01-24 Interventions: Drug: celecoxib |
Completed |
Study Name: Fenretinide in Treating Patients With Leukoplakia of the Mouth Condition: Head and Neck Cancer Date: 1999-12-10 Interventions: Drug: fenretinide Drug: Placebo |